Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)

v3.10.0.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Income Statement [Abstract]        
Net sales $ 11,105 $ 5,008 $ 31,945 $ 7,420
Cost of goods sold 3,922 1,722 11,511 5,001
Gross profit 7,183 3,286 20,434 2,419
Costs and expenses:        
Research and development 2,904 5,876 9,140 46,346
Selling, general and administrative 33,887 45,110 108,647 140,083
Total operating expenses 36,791 50,986 117,787 186,429
Loss from operations (29,608) (47,700) (97,353) (184,010)
Other Income (Expense)        
Interest expense, net (3,369) (1,226) (9,697) (2,361)
Debt conversion expense 0 0 0 (1,209)
State R&D tax credits 0 0 30 0
Change in fair value of derivative financial instruments-warrants (433) 55 7,815 216
Total other expense (3,802) (1,171) (1,852) (3,354)
Loss before taxes (33,410) (48,871) (99,205) (187,364)
Tax expense (1,133) 0 (1,133) 0
Net loss $ (34,543) $ (48,871) $ (100,338) $ (187,364)
Weighted Average Common Shares Outstanding        
Basic and Diluted (in shares) 247,994,922 224,954,941 247,221,231 221,854,099
Net Loss per Common Share, Basic and Diluted        
Net Loss per Common Share, Basic and Diluted (in dollars per share) $ (0.14) $ (0.22) $ (0.41) $ (0.84)